# FDA 483 - Maria E. De La Torre Silva, MD - July 15, 2025

Source: https://www.globalkeysolutions.net/records/483/maria-e-de-la-torre-silva-md/b5291641-216e-44e0-80c5-711b684de74c

> FDA 483 for Maria E. De La Torre Silva, MD on July 15, 2025. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Maria E. De La Torre Silva, MD
- Inspection Date: 2025-07-15
- Product Type: drugs
- Office Name: Florida District Office
- Summary: An FDA inspection of West Palm Quality Research, a clinical investigator in West Palm Beach, FL, revealed significant deficiencies in the conduct of clinical trials. The firm failed to adhere to investigational plans, including not conducting a protocol, enrolling subjects who met exclusion criteria, and administering expired investigational product. Additionally, the firm failed to maintain accurate case histories, with discrepancies noted between dispensed and returned investigational products.

## Related Officers

- [Angelica M. Chica](https://www.globalkeysolutions.net/people/angelica-m-chica/117a5aa3-e5ed-46f2-bf32-885591c34848)
- [issuing_officer](https://www.globalkeysolutions.net/people/sheri-l-stephenson/dd4f3755-bb3b-4a14-a08f-8d59fbb0b6fa)

Company: https://www.globalkeysolutions.net/companies/maria-e-de-la-torre-silva-md/616e8549-101a-4c07-afd0-ee65d4da33c5

Office: https://www.globalkeysolutions.net/offices/florida-district-office/95b2a118-0b78-46e0-a54c-982bd7ce51c9